Exploratory analysis of palbociclib benefit in the PALLAS trial by SETERPR index and prior chemotherapy regimens (ABCSG-42/AFT-05/BIG-14-13)

Category Primary study
ConferenceSan Antonio Breast Cancer Symposium 2025
Year 2026
This article has no abstract
Epistemonikos ID: 5cbc3eba33fc0ae494a1c3bbbba1c9d9eb3d0bb9
First added on: Jun 06, 2026